Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Khoo

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Vascular Pharmacology|December 28, 2014
Genetic therapies to lower cholesterolBernard Khoo
The Lancet. Diabetes & Endocrinology|March 25, 2018
Once-daily, modified-release hydrocortisone in patients with adrenal insufficiencyBernard Khoo
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Antisense-mediated exon-skipping to induce gene knockdownPetra Disterer, Bernard Khoo
Current Opinion in Molecular Therapeutics|March 31, 2009
Splicing therapeutics in SMN2 and APOBBernard Khoo, Adrian R Krainer
Lancet (London, England)|June 23, 2025
GLP-1 and amylin receptor multiagonism with amycretin for obesity managementBernard Khoo, Tricia M-M Tan
Nature Reviews. Endocrinology|May 7, 2024
Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitusSaleem Ansari, Bernard Khoo, Tricia Tan
Nature Reviews. Endocrinology|April 17, 2024
Targeting the incretin system in obesity and type 2 diabetes mellitusSaleem Ansari, Bernard Khoo, Tricia Tan
Lancet (London, England)|October 21, 2021
Surpassing insulin glargine in type 2 diabetes with tirzepatideBernard Khoo, Tricia M-M Tan
The Lancet. Diabetes & Endocrinology|February 8, 2022
Steps to redressing an imbalance: GLP-1 analogues for obesity in east AsiaTricia M-M Tan, Bernard Khoo
The Lancet. Diabetes & Endocrinology|February 8, 2024
GLP-1 analogue therapy for obesity in people from AsiaBernard Khoo, Tricia M-M Tan
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Vascular Pharmacology|December 28, 2014
Genetic therapies to lower cholesterolBernard Khoo
The Lancet. Diabetes & Endocrinology|March 25, 2018
Once-daily, modified-release hydrocortisone in patients with adrenal insufficiencyBernard Khoo
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Antisense-mediated exon-skipping to induce gene knockdownPetra Disterer, Bernard Khoo
Current Opinion in Molecular Therapeutics|March 31, 2009
Splicing therapeutics in SMN2 and APOBBernard Khoo, Adrian R Krainer
Lancet (London, England)|June 23, 2025
GLP-1 and amylin receptor multiagonism with amycretin for obesity managementBernard Khoo, Tricia M-M Tan
Nature Reviews. Endocrinology|May 7, 2024
Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitusSaleem Ansari, Bernard Khoo, Tricia Tan
Nature Reviews. Endocrinology|April 17, 2024
Targeting the incretin system in obesity and type 2 diabetes mellitusSaleem Ansari, Bernard Khoo, Tricia Tan
Lancet (London, England)|October 21, 2021
Surpassing insulin glargine in type 2 diabetes with tirzepatideBernard Khoo, Tricia M-M Tan
The Lancet. Diabetes & Endocrinology|February 8, 2022
Steps to redressing an imbalance: GLP-1 analogues for obesity in east AsiaTricia M-M Tan, Bernard Khoo
The Lancet. Diabetes & Endocrinology|February 8, 2024
GLP-1 analogue therapy for obesity in people from AsiaBernard Khoo, Tricia M-M Tan
Pageof 8